Syntec Optics (Nasdaq: OPTX) Enabling Optics for Blindness
ROCHESTER, NEW YORK, Feb. 27, 2024 (GLOBE NEWSWIRE) — Syntec Optics, a scientific technical instruments, aerospace and defense optics provider […]
Lilium releases Full Year and Fourth Quarter 2023 Shareholder Letter
MUNICH, Germany, Feb. 27, 2024 (GLOBE NEWSWIRE) — Lilium N.V. (Nasdaq: LILM) (“Lilium”), developer of the first all-electric vertical take-off […]
Beam Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Reiterates Anticipated Milestones
Patient Dosing and Enrollment Continue to Progress in Beacon Phase 1/2 Study of BEAM-101 in Severe Sickle Cell Disease; First […]
Hesai Group to Report Fourth Quarter and Full Year 2023 Financial Results on Monday, March 11, 2024
SHANGHAI, China, Feb. 27, 2024 (GLOBE NEWSWIRE) — Hesai Group (“Hesai,” “Hesai Technology” or the “Company”) (NASDAQ: HSAI), the global […]
HighPeak Energy, Inc. Announces 2023 Fourth Quarter and Yearend Earnings Release and Conference Call Dates
FORT WORTH, Texas, Feb. 27, 2024 (GLOBE NEWSWIRE) — HighPeak Energy, Inc. (NASDAQ: HPK) (“HighPeak Energy”), today announced that it […]
AirSculpt Technologies Reports Double Digit Revenue Growth for the Fourth Quarter and Full Year 2023
MIAMI BEACH, Fla., Feb. 27, 2024 (GLOBE NEWSWIRE) — AirSculpt Technologies, Inc. (NASDAQ:AIRS)(“AirSculpt” or the “Company”), a national provider of […]
Millicom (Tigo) Q4 2023 Earnings Release
Millicom (Tigo) Q4 2023 Earnings Release Luxembourg, February 27, 2024 – Millicom is pleased to announce its fourth quarter 2023 results. […]
Esperion Reports Fourth Quarter and Full Year 2023 Financial Results
– FY23 U.S. Net Product Revenue Grew 40% Y/Y to $78.3 Million; FY23 Total Revenue Grew 54% Y/Y to $116.3 […]
Greenwich LifeSciences Flamingo-01 Phase III Clinical Trial Approved to Expand into Five Largest European Countries
STAFFORD, Texas, Feb. 27, 2024 (GLOBE NEWSWIRE) — Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the “Company”), a clinical-stage biopharmaceutical company focused […]
Privia Health Reports Fourth Quarter and Full-Year 2023 Financial Results
Achieved All 2023 Operating and Financial Guidance Metrics Implemented Providers +19.4% compared to Year-End 2022 Introduces Full-Year 2024 Guidance Proactive […]
